CSIMarket


Candel Therapeutics Inc   (CADL)
Other Ticker:  
 
 

CADL's Revenue Growth by Quarter and Year

Candel Therapeutics Inc 's Revenue results by quarter and year




CADL Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 0.00 0.00 0.00
III Quarter September 0.03 0.00 0.00 0.00
II Quarter June 0.03 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.06 - - -



CADL Revenue third quarter 2021 Y/Y Growth Comment
Candel Therapeutics Inc in the third quarter achieved Revenue of $ 0.03 millions compare to recorded in same quarter a year ago.

Looking into third quarter results within Biotechnology & Pharmaceuticals industry 65 other companies have achieved higher Revenue growth. While Candel Therapeutics Inc ' s Revenue no change of % ranks overall at the positon no. 2215 in the third quarter.




CADL Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Candel Therapeutics Inc 's third quarter 2021 Revenue $ 0.03 millions CADL's Income Statement
Candel Therapeutics Inc 's third quarter 2020 Revenue $ 0.00 millions Quarterly CADL's Income Statement
New: More CADL's historic Revenue Growth >>


CADL Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September 3.33 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #66
Healthcare Sector #338
Overall #2215

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Sep 30 2021)  
Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #66
Healthcare Sector #338
Overall #2215
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Sep 30 2021)  

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Candel Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
(Sep 30 2021)  


CADL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2021 Candel Therapeutics Inc disclosed growth in Revenue sequentially by 3.33% to $ 0.03 millions, from $ 0.03 millions released a quarter before.

Within Biotechnology & Pharmaceuticals industry 70 other companies have achieved higher Revenue quarter on quarter growth. While Candel Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 2458.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #71
Healthcare Sector #367
Overall #2458
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #71
Healthcare Sector #367
Overall #2458
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
(Sep 30 2021)  


CADL's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2021 Candel Therapeutics Inc disclosed growth in Revenue from the previous quarter by 3.33% to $ 0.03 millions, from $ 0.03 millions declared in the previous quarter.

Within Biotechnology & Pharmaceuticals industry 70 other companies have achieved higher Revenue quarter on quarter growth. While Candel Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 2458.


Candel Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Sep 30 2021 period, Candel Therapeutics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Candel Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2021 period, Candel Therapeutics Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Candel Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CADL's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CADL's Competitors
Revenue Growth for Candel Therapeutics Inc 's Suppliers
Revenue Growth for CADL's Customers

You may also want to know
CADL's Annual Growth Rates CADL's Profitability Ratios CADL's Asset Turnover Ratio CADL's Dividend Growth
CADL's Roe CADL's Valuation Ratios CADL's Financial Strength Ratios CADL's Dividend Payout Ratio
CADL's Roa CADL's Inventory Turnover Ratio CADL's Growth Rates CADL's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2021
Enanta Pharmaceuticals Inc-0.24%$ -0.237 millions
Zimmer Biomet Holdings Inc -0.27%$ -0.275 millions
Community Health Systems Inc -0.35%$ -0.352 millions
Quest Diagnostics Inc-0.43%$ -0.431 millions
Twinlab Consolidated Holdings Inc -0.54%$ -0.539 millions
Repro Med Systems Inc -0.65%$ -0.654 millions
Avanos Medical Inc -0.86%$ -0.862 millions
Cytomx Therapeutics Inc -1.13%$ -1.130 millions
Bausch Health Companies Inc -1.26%$ -1.263 millions
Xtant Medical Holdings Inc -1.71%$ -1.705 millions
Mimedx Group Inc -1.91%$ -1.911 millions
Clovis Oncology inc -2.21%$ -2.208 millions
Teva Pharmaceutical Industries Ltd-2.29%$ -2.288 millions
Aziyo Biologics inc -2.45%$ -2.455 millions
Alimera Sciences Inc -2.57%$ -2.566 millions
Nuwellis Inc -2.68%$ -2.679 millions
Pressure Biosciences Inc -2.90%$ -2.903 millions
Lifevantage Corp-2.92%$ -2.924 millions
Immunitybio inc -2.94%$ -2.941 millions
Fitlife Brands Inc -3.15%$ -3.149 millions
Luna Innovations Inc-3.43%$ -3.425 millions
Cardiovascular Systems Inc -3.59%$ -3.591 millions
Vyant Bio Inc -3.95%$ -3.954 millions
Hologic Inc-4.28%$ -4.279 millions
Supernus Pharmaceuticals inc -4.30%$ -4.300 millions
Procyon Corp-4.51%$ -4.515 millions
Healthcare Services Group Inc -4.67%$ -4.670 millions
Star Equity Holdings Inc -4.92%$ -4.922 millions
Ayala Pharmaceuticals Inc -5.02%$ -5.015 millions
Recro Pharma Inc -5.44%$ -5.444 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DCLT's Profile

Stock Price

DCLT's Financials

Business Description

Fundamentals

Charts & Quotes

DCLT's News

Suppliers

DCLT's Competitors

Customers & Markets

Economic Indicators

DCLT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071